作者：
Jiayun,Chen [1]
;
Peng,Gao [2]
;
Wei,Xiao [3]
;
Guangqing,Cheng [2]
;
Sanjeev,Krishna [4]
;
Jianyou,Wang [2]
;
Yin Kwan,Wong [5]
;
Chen,Wang [2]
;
Liwei,Gu [2]
;
Dong Hua,Yang [6]
;
Jigang,Wang [7]
作者单位：
Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China; Department of Critical Medicine, and Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People's Hospital, First Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518020, Guangdong, China.
[1]
Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
[2]
Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong Pharmaceutical University, Guangzhou 510006, Guangdong, China.
[3]
Clinical Academic Group in Institute for Infection & Immunity, St George's University of London, London, United Kingdom; St George's University Hospitals NHS Foundation Trust, United Kingdom; Institut für Tropenmedizin, Universitätsklinikum Tübingen, Tübingen, Germany.
[4]
Department of Critical Medicine, and Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People's Hospital, First Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518020, Guangdong, China.
[5]
New York College of Traditional Chinese Medicine Mineola, United States. Electronic address: Yangd1@stjohns.edu.
[6]
Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China; Department of Critical Medicine, and Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People's Hospital, First Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518020, Guangdong, China. Electronic address: jgwang@icmm.ac.cn.
[7]
DOI
10.1016/j.drup.2023.100978
PMID
37385107
发布时间
2023-08-15
换一批
换一批
